X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Cadila Healthcare Fact Sheet, Cadila Healthcare Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cadila Healthcare Fact Sheet   (CADIL)

Here is the latest financial fact sheet of Cadila Healthcare. For more details, see the Cadila Healthcare quarterly results and Cadila Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.

CADILA HEALTHCARE Price History

Price Rs 347.8
Mkt Cap Rs m 356,006
Vol '000 41.6
P/E X 23.0
P/CF X 19.2
EPS (TTM) Rs 15.1
% ch % 1.2
No. of shares m 1,023.74
% ch week % -9.5
% ch 1-mth % -12.8
% ch 12-mth % -24.0
52 week H/L Rs 558.0/341.7
(As on May 23, 2018 02:07:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CADILA HEALTHCARE Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
CADILA HEALTHCARE EQUITY SHARE DATA
High Rs9641,0791,763454460 
Low Rs695631872305305 
Sales per share (Unadj.) Rs310.5352.8422.592.192.1 
Earnings per share (Unadj.) Rs31.939.256.219.214.8 
Diluted earnings per shareRs6.47.811.219.214.8 
Cash flow per share (Unadj.) Rs40.949.170.222.018.5 
Dividends per share (Unadj.) Rs7.509.0012.003.203.20 
Adj. dividends per shareRs1.501.802.403.203.20 
Dividend yield (eoy) %0.91.10.90.80.8 
Book value per share (Unadj.) Rs143.8168.0220.855.768.0 
Adj. book value per shareRs28.833.644.255.768.0 
Shares outstanding (eoy) m204.75204.75204.751,023.741,023.74 
Bonus/Rights/Conversions  ---FV5:1- 
Price / Sales ratio x2.72.43.14.14.2 
Avg P/E ratio x26.021.823.419.825.8 
P/CF ratio (eoy) x20.317.418.817.220.7 
Price / Book Value ratio x5.85.16.06.85.6 
Dividend payout %23.522.921.416.721.6 
Avg Mkt Cap Rs m169,840175,061269,758388,458391,581 
No. of employees `00012.212.213.215.416.9 
Total wages/salary Rs m9,04210,71112,08512,61615,002 
Avg. sales/employee Rs Th5,214.65,908.26,564.06,105.05,594.5 
Avg. wages/employee Rs Th741.6876.0916.9817.0890.1 
Avg. net profit/employee Rs Th536.0657.2873.01,272.1899.9 
CADILA HEALTHCARE INCOME DATA
Net Sales Rs m63,57772,24086,51394,26894,295 
Other income Rs m3705075541,1561,286 
Total revenues Rs m63,94772,74787,06795,42495,581 
Gross profit Rs m11,25112,00117,59923,30519,036 
Depreciation Rs m1,8472,0122,8732,9213,750 
Interest Rs m1,687902679528450 
Profit before tax Rs m8,0879,59414,60121,01216,122 
Minority Interest Rs m-364-326-397430338 
Prior Period Items Rs m-132654200 
Extraordinary Inc (Exp) Rs m0-172-104-25-3 
Tax Rs m1,1751,3252,6361,7741,289 
Profit after tax Rs m6,5358,03611,50619,64315,168 
Gross profit margin %17.716.620.324.720.2 
Effective tax rate %14.513.818.18.48.0 
Net profit margin %10.311.113.320.816.1 
CADILA HEALTHCARE BALANCE SHEET DATA
Current assets Rs m31,91734,37940,88742,80460,223 
Current liabilities Rs m26,70428,14029,92134,61053,058 
Net working cap to sales %8.28.612.78.77.6 
Current ratio x1.21.21.41.21.1 
Inventory Days Days7069605270 
Debtors Days Days5557696888 
Net fixed assets Rs m37,61240,15340,52646,98772,984 
Share capital Rs m1,0241,0241,0241,0241,024 
"Free" reserves Rs m23,82627,84544,18455,96868,576 
Net worth Rs m29,44534,39045,20856,99269,600 
Long term debt Rs m14,26013,62211,5048,96424,684 
Total assets Rs m73,74279,86591,342105,506152,207 
Interest coverage x5.811.622.540.836.8 
Debt to equity ratio x0.50.40.30.20.4 
Sales to assets ratio x0.90.90.90.90.6 
Return on assets %11.111.213.319.110.3 
Return on equity %22.223.425.534.521.8 
Return on capital %21.521.426.133.317.9 
Exports to sales %24.327.732.547.20 
Imports to sales %6.45.86.26.20 
Exports (fob) Rs m15,44220,03828,08044,5370 
Imports (cif) Rs m4,0734,2105,3915,8380 
Fx inflow Rs m16,23620,61329,66644,88121,280 
Fx outflow Rs m6,6206,8648,0939,06910,874 
Net fx Rs m9,61613,74921,57335,81210,406 
CADILA HEALTHCARE CASH FLOW
From Operations Rs m 6,034 9,028 9,936 18,935 13,495 
From Investments Rs m -6,823 -4,380 -4,647 -8,635 -29,103 
From Financial Activity Rs m 2,858 -5,287 -3,511 -9,348 23,158 
Net Cashflow Rs m 2,069 -639 1,778 991 7,556 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 8.3%
FIIs 5.9%
ADR/GDR 0.0%
Free float 11.0%
Shareholders 44,069
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Zydus Tower, Satellite Cross Roads, Ahmedabad - 380 015
E-MAIL upen.shah@zyduscadila.com WEB www.zyduscadila.com
TELEPHONE (079) 2686 8326 FAX (079) 2686 2365
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Sharepro Serv.,416-420, Devnandan Mall, Ellisbridge, Ahmedabad-09
AUDITOR Mukesh M. Shah & Co.
CHM: Pankaj R. Patel (MD) COMP SEC: Upen H. Shah YEAR OF INC: 1995 BSE CODE: 532321 FV (Rs): 5 DIV YIELD (%): 0.9

More Pharmaceuticals Company Fact Sheets:   PIRAMAL ENTERPRISES  NOVARTIS  FULFORD INDIA  STRIDES SHASUN LTD  MERCK LTD  

Compare CADILA HEALTHCARE With:   PIRAMAL ENTERPRISES  NOVARTIS  FULFORD INDIA  STRIDES SHASUN LTD  MERCK LTD  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Flat; Oil & Gas Sector Down 2.3%(12:30 pm)

Share markets in India are presently trading near the dotted line. Sectoral indices are trading on a mixed note with stocks in the metal sector.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - ACTAVIS COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS